tiprankstipranks
Advertisement
Advertisement
Analyst Reiterates Buy on MIST, Maintains $8 Price Target on Strong CARDAMYST Launch and Expanded AFib Opportunity
PremiumRatingsAnalyst Reiterates Buy on MIST, Maintains $8 Price Target on Strong CARDAMYST Launch and Expanded AFib Opportunity
1M ago
Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c
Premium
The Fly
Milestone Pharmaceuticals reports Q1 EPS (20c), consensus 19c
1M ago
Milestone Pharmaceuticals (MIST) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Milestone Pharmaceuticals (MIST) Q1 Earnings Cheat Sheet
1M ago
Regulatory Disruptions Pose Material Operational Risks for Milestone Pharmaceuticals
PremiumCompany AnnouncementsRegulatory Disruptions Pose Material Operational Risks for Milestone Pharmaceuticals
3M ago
Milestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target
Premium
Ratings
Milestone: Early CARDAMYST Launch Progress and Solid Cash Position Underscore Buy Rating and $8 Target
3M ago
Midday Fly By: FedEx reports ‘beat and raise,’ Ecolab to acquire CoolIT
Premium
The Fly
Midday Fly By: FedEx reports ‘beat and raise,’ Ecolab to acquire CoolIT
3M ago
Milestone Pharmaceuticals (MIST) Q4 Earnings Cheat Sheet
PremiumPre-EarningsMilestone Pharmaceuticals (MIST) Q4 Earnings Cheat Sheet
3M ago
Milestone Pharmaceuticals to present Cardamyst data at ACC 26
Premium
The Fly
Milestone Pharmaceuticals to present Cardamyst data at ACC 26
3M ago
Milestone Pharmaceuticals Sets March 20 Call for 2025 Results and Business Update
Premium
Company Announcements
Milestone Pharmaceuticals Sets March 20 Call for 2025 Results and Business Update
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100